Selected article for: "acute respiratory and long effective"
Author: Seeherman, Sarah; Suzuki, Yuichiro J.
Title: Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
  • Cord-id: tfiobdd4
  • Document date: 2021_2_7
    • ID: tfiobdd4
    Snippet: The current pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While this respiratory virus only causes mild symptoms in younger healthy individuals, elderly people and those with cardiovascular diseases such as systemic hypertension are susceptible to developing severe conditions that can be fatal. SARS-CoV-2 infection is also associated with an increased incidence of cardiovascular diseases such as myocardial injury, acute
    Document: The current pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While this respiratory virus only causes mild symptoms in younger healthy individuals, elderly people and those with cardiovascular diseases such as systemic hypertension are susceptible to developing severe conditions that can be fatal. SARS-CoV-2 infection is also associated with an increased incidence of cardiovascular diseases such as myocardial injury, acute coronary syndrome, and thromboembolism. Understanding the mechanisms of the effects of this virus on the cardiovascular system should thus help develop therapeutic strategies to reduce the mortality and morbidity associated with SARS-CoV-2 infection. Since this virus causes severe and fatal conditions in older individuals with cardiovascular comorbidities, effective therapies targeting specific populations will likely contribute to ending this pandemic. In this review article, the effects of various viruses—including other coronaviruses, influenza, dengue, and human immunodeficiency virus—on the cardiovascular system are described to help provide molecular mechanisms of pathologies associated with SARS-CoV-2 infection and COVID-19. The goal is to provide mechanistic information from the biology of other viral infections in relation to cardiovascular pathologies for the purpose of developing improved vaccines and therapeutic agents effective in preventing and/or treating the acute and long-term consequences of SARS-CoV-2 and COVID-19.

    Search related documents:
    Co phrase search for related documents
    • activator signal transducer and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • activator signal transducer and acute ards respiratory distress syndrome cause: 1
    • activator signal transducer and adhesion molecule: 1, 2, 3, 4
    • activator signal transducer and lung damage: 1, 2
    • activator signal transducer and lung finding: 1
    • acute ards respiratory distress syndrome and adhesion molecule: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and low concentration: 1
    • acute ards respiratory distress syndrome and low respiratory tract: 1, 2
    • acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung endothelium: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung finding: 1, 2
    • acute ards respiratory distress syndrome cause and lung damage: 1, 2, 3, 4
    • acute ards respiratory distress syndrome cause and lung failure: 1
    • acute cardiac injury and lung damage: 1, 2
    • acute cardiac injury and lung failure: 1, 2, 3
    • acute coronary syndrome and lung damage: 1, 2
    • acute coronary syndrome and lung failure: 1, 2
    • acute phase and lung failure: 1, 2, 3